Literaturangaben

Zeitschrift für Infektionstherapie 2.2023

Aktuelle Epidemiologie und Diagnostik in der Mikrobiologie

Candida auris (Seite 15)

1.    Weltgesundheitsorganisation (WHO). WHO fungal priority pathogens list to guide research, development and public health action. 2022. ISBN 978-92-4-006024-1. https://www.who.int/news/item/25-10-2022-who-releases-first-ever-list-of-health-threatening-fungi

2.    Satoh K, Makimura K, Hasumi Y, Nishiyama Y, Uchida K, Yamaguchi H. Candida auris sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese hospital. Microbiol Immunol 2009; 53: 41–44. PMID: 19161556.

3.    Wagener J, Kurzai O. Candida auris: Steckbrief eines neuen Pilzes. Dtsch Arztebl 2019; 116:4-7.

4.    https://www.cdc.gov/fungal/candida-auris/index.html

5.    Fakhim H, Vaezi A, Dannaoui E, Chowdhary A, Nasiry D, Faeli L, Meis JF, Badali H. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model. Mycoses 2018; 61:377-382. PMID: 29460345.

6.    Borman AM, Szekely A, Johnson EM. Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species. mSphere 2016; 1(4):e00189-16. PMID: 27547827. PMCID: PMC4990711.

7.    Osei Sekyere J. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. Microbiologyopen 2018; 7:e00578. PMID: 29345117. PMCID: PMC6079168.

8.    Chen J, Tian S, Han X, Chu Y, Wang Q, Zhou B, Shang H. Is the superbug fungus really so scary? A systematic review and meta-analysis of global epidemiology and mortality of Candida auris. BMC Infect Dis 2020; 20:827. PMID: 33176724. PMCID: PMC7656719.

9.    Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, Wisplinghoff H, Vehreschild JJ. Morbidity and mortality of candidaemia in Europe: an epidemiologic meta-analysis. Clin Microbiol Infect 2019; 25:1200-1212. PMID: 31039444.

10.    Lockhart SR, Etienne KA, Vallabhaneni S, Farooqi J, Chowdhary A, Govender NP, Colombo AL, Calvo B, Cuomo CA, Desjardins CA, Berkow EL, Castanheira M, Magobo RE, Jabeen K, Asghar RJ, Meis JF, Jackson B, Chiller T, Litvintseva AP. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin Infect Dis 2017; 64:134-140. PMID: 27988485. PMCID: PMC5215215.

11.    Jacobs SE, Zagaliotis P, Walsh TJ. Novel antifungal agents in clinical trials. F1000Res 2021; 10:507. PMID: 35136573. PMCID: PMC8787557.

12.    Hoenigl M, Sprute R, Egger M, Arastehfar A, Cornely OA, Krause R, Lass-Flörl C, Prattes J, Spec A, Thompson GR, Wiederhold N, Jenks JD. The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin. Drugs 2021; 81:1703-1729. PMID: 34626339. PMCID: PMC8501344.

13.    de J Treviño-Rangel R, González GM, Montoya AM, Rojas OC, Elizondo-Zertuche M, Álvarez-Villalobos NA. Recent antifungal pipeline developments against Candida auris: a systematic review. J Fungi (Basel) 2022; 8:1144. PMID: 36354911.

14.    Hoenigl M, Sprute R, Arastehfar A, Perfect JR, Lass-Flörl C, Bellmann R, Prattes J, Thompson GR 3rd, Wiederhold NP, Al Obaidi MM, Willinger B, Arendrup MC, Koehler P, Oliverio M, Egger M, Schwartz IS, Cornely OA, Pappas PG, Krause R. Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action. Expert Opin Investig Drugs 2022; 31:795-812. PMID: 35657026. PMCID: PMC9339492.

15.    Allert S, Schulz D, Kämmer P, Großmann P, Wolf T, Schäuble S, Panagiotou G, Brunke S, Hube B. From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris. Virulence 2022; 13:191-214. PMID: 35142597. PMCID: PMC8837256.

16.    Schelenz S, Hagen F, Rhodes JL, Abdolrasouli A, Chowdhary A, Hall A, Ryan L, Shackleton J, Trimlett R,  Meis JF, Armstrong-James D, Fisher MC. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob Resist Infect Control 2016; 5:35. PMID: 27777756. PMCID: PMC5069812.

17.    Sabino R, Veríssimo C, Pereira ÁA, Antunes F. Candida auris, an agent of hospital-associated outbreaks: which challenging issues do we need to have in mind? Microorganisms 2020; 8:181. PMID: 32012865. PMCID: PMC7074697.

18.    Mulet Bayona JV, Tormo Palop N, Salvador García C, Herrero Rodríguez P, Abril López de Medrano V, Ferrer Gómez C, Gimeno Cardona C. Characteristics and management of candidaemia episodes in an established Candida auris outbreak. Antibiotics (Basel) 2020; 9:558. PMID: 32872580. PMCID: PMC7559407.

19.    Farooqi JQ, Soomro AS, Baig MA, Sajjad SF, Hamid K, Jabeen K, Naqvi MF, Nasir N, Roshan R, Mahmood SF, Zafar A, Asghar RJ. Outbreak investigation of Candida auris at a tertiary care hospital in Karachi, Pakistan. J Infect Prev 2020; 21:189-195. PMID: 33193821. PMCID: PMC7607399.

20.    Di Pilato V, Codda G, Ball L, Giacobbe DR, Willison E, Mikulska M, Magnasco L, Crea F, Vena A, Pelosi P, Bassetti M, Marchese A. Molecular epidemiological investigation of a nosocomial cluster of C. auris: evidence of recent emergence in Italy and ease of transmission during the COVID-19 pandemic. J Fungi (Basel) 2021; 7:140. PMID: 33672021. PMCID: PMC7919374.

21.    Eckbo EJ, Wong T, Bharat A, Cameron-Lane M, Hoang L, Dawar M, Charles M. First reported outbreak of the emerging pathogen Candida auris in Canada. Am J Infect Control 2021; 49:804-807. PMID: 33485922.

22.    Hinrichs C, Wiese-Posselt M, Graf B, Geffers C, Weikert B, Enghard P, Aldejohann A, Schrauder A, Knaust A, Eckardt KU, Gastmeier P, Kurzai O. Successful control of Candida auris transmission in a German COVID-19 intensive care unit. Mycoses 2022; 65:643-649. PMID: 35419847. PMCID: PMC9115290.

23.    Aldejohann AM, Wiese-Posselt M, Gastmeier P, Kurzai O. Expert recommendations for prevention and management of Candida auris transmission. Mycoses 2022; 65:590-598. PMID: 35437832.

24.    Mulet Bayona JV, Salvador García C, Tormo Palop N, Gimeno Cardona C. Evaluation of a novel chromogenic medium for Candida spp. identification and comparison with CHROMagar™ Candida for the detection of Candida auris in surveillance samples. Diagn Microbiol Infect Dis 2020; 98:115168. PMID: 32927410.

25.    Borman AM, Fraser M, Johnson EM. CHROMagarTM Candida Plus: A novel chromogenic agar that permits the rapid identification of Candida auris. Med Mycol 2021; 59:253-258. PMID: 32525988.

26.    Marathe A, Zhu Y, Chaturvedi V, Chaturvedi S. Utility of CHROMagar™ Candida Plus for presumptive identification of Candida auris from surveillance samples. Mycopathologia 2022. Online ahead of print. PMID: 36355325.

27.    Kathuria S, Singh PK, Sharma C, Prakash A, Masih A, Kumar A, Meis JF, Chowdhary A. Multidrug-resistant Candida auris misidentified as Candida haemulonii: characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J Clin Microbiol 2015; 53:1823-1830. PMID: 25809970. PMCID: PMC4432077.

28.    https://www.cdc.gov/fungal/candida-auris/pdf/Testing-algorithm_by-Method_508.pdf

29.    Hamprecht A, Barber AE, Mellinghoff SC, Thelen P, Walther G, Yu Y, Neurgaonkar P, Dandekar T, Cornely OA, Martin R, Kurzai O, German Candida auris Study Group. Candida auris in Germany and previous exposure to foreign healthcare. Emerg Infect Dis 2019; 25:1763-1765. PMID: 31223105. PMCID: PMC6711216.

30.    Steinmann J, Schrauzer T, Kirchhoff L, Meis JF, Rath PM. Two Candida auris cases in Germany with no recent contact to foreign healthcare-epidemiological and microbiological investigations. J Fungi (Basel) 2021; 7:380. PMID: 34066140. PMCID: PMC8151845.